Home > Balance Sheet > CORONA REMEDIES

CORONA REMEDIES
Contingent Liabilities

    Back to Balance Sheet
CORONA REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CORONA REMEDIES
Please provide your vote to see the results

CORONA REMEDIES Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023
Contingent Liabilities ₹1.01 Cr---

What is the latest Contingent Liabilities ratio of CORONA REMEDIES ?

The latest Contingent Liabilities ratio of CORONA REMEDIES is ₹1.01 Cr based on Mar2026 Consolidated results.
Year Contingent Liabilities
Mar2026₹1.01 Cr
Mar2025-
Mar2024-
Mar2023-

How is Contingent Liabilities of CORONA REMEDIES Trending?

Years Contingent Liabilities % Change
Mar2026 ₹1.01 Cr
0
Mar2025 -
0
Mar2024 -
0
Mar2023 - -

Compare Contingent Liabilities of peers of CORONA REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CORONA REMEDIES ₹12,748.3 Cr -2.9% -0.3% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹460,696.0 Cr 0.5% -4% 15.7% Stock Analytics
DIVIS LABORATORIES ₹246,063.0 Cr 9.1% 18.2% 47.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹191,515.0 Cr 3.6% 3.4% 36.4% Stock Analytics
CIPLA ₹114,554.0 Cr -1.2% -3.3% -10.8% Stock Analytics
DR REDDYS LABORATORIES ₹98,308.6 Cr -1.4% 2.9% -8% Stock Analytics


CORONA REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CORONA REMEDIES

-2.9%

-0.3%

NA
SENSEX

-0.4%

-0.5%

-5.8%


You may also like the below Video Courses